If you have a discount code, please enter it upon checkout or create an account for exclusive customer discounts, newsletters and information tips..
Cart 0

About us

CellOxess (Europe) Ltd

We all experience some degree of oxidative stress in our daily lives.  The key to maintaining overall health and vitality is to lower the oxidative load our body experiences.  Antioxidants are nature’s defense molecules used by cells to fight off predisease. Without antioxidants cells cannot survive.

CellOxess is dedicated to the amelioration of chronic oxidative stress to support cardiovascular, metabolic, neurological and reproductive health.  The company’s mission is to identify tissue-specific diagnostic biomarkers of oxidative stress and treat the condition before disease becomes manifest. Accordingly, our scientific philosophy is focused on promoting overall health and well-being. As a biotechnology company, we are committed to understanding the biomolecular role of antioxidants and their synergistic actions in maintaining cell homeostasis necessary for normal tissue function. Furthermore, by applying the principles of drug design and delivery, CellOxess is vigorously engaged in the development of clinically proven, safe and efficacious antioxidant formulations to restore the natural cellular balance and support structures and functions of the body. Our immediate focus is to restore the natural antioxidant balance of the reproductive system in order to optimize reproductive health. Reducing oxidative stress with specific combinations of antioxidants will, in turn, restore sperm and oocyte optimal health.

Celloxess, LLC, is a privately held Delaware registered biotechnology company with headquarters located in Princeton, New Jersey, USA. The founder and chief executive officer, Dr. Parviz Gharagozloo, is a medicinal chemist with over 25 years of experience in drug design and development gained in academia, technology transfer and pharmaceutical companies in the UK and USA. The company has strong research links with university departments pioneering fertility research in Spain, France, Australia, UK and USA. Where possible, CellOxess endeavors to generate robust preclinical and/or clinical evidence to support its products.

CellOxess (Europe) Ltd was formed in 2017 to bring the pioneering work in this field to the UK and Rest of the World.

Contact Us at :

CellOxess (Europe) Ltd

Abbey House, 1650 Arlington Business Park, Theale

Reading, RG7 4SA, UK

Tel: +44 (0) 1908 010090

Email: info@celloxess.co.uk